Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis

Sci Rep. 2017 Mar 22:7:44618. doi: 10.1038/srep44618.

Abstract

Through a process called perilacunar remodeling, bone-embedded osteocytes dynamically resorb and replace the surrounding perilacunar bone matrix to maintain mineral homeostasis. The vital canalicular networks required for osteocyte nourishment and communication, as well as the exquisitely organized bone extracellular matrix, also depend upon perilacunar remodeling. Nonetheless, many questions remain about the regulation of perilacunar remodeling and its role in skeletal disease. Here, we find that suppression of osteocyte-driven perilacunar remodeling, a fundamental cellular mechanism, plays a critical role in the glucocorticoid-induced osteonecrosis. In glucocorticoid-treated mice, we find that glucocorticoids coordinately suppress expression of several proteases required for perilacunar remodeling while causing degeneration of the osteocyte lacunocanalicular network, collagen disorganization, and matrix hypermineralization; all of which are apparent in human osteonecrotic lesions. Thus, osteocyte-mediated perilacunar remodeling maintains bone homeostasis, is dysregulated in skeletal disease, and may represent an attractive therapeutic target for the treatment of osteonecrosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Bone Matrix / drug effects
  • Bone Matrix / metabolism
  • Bone Matrix / pathology
  • Bone Remodeling / drug effects*
  • Cathepsin K / genetics
  • Cathepsin K / metabolism
  • Delayed-Action Preparations / administration & dosage
  • Gene Expression Regulation / drug effects*
  • Glucocorticoids / adverse effects*
  • Humans
  • Male
  • Matrix Metalloproteinase 13 / genetics
  • Matrix Metalloproteinase 13 / metabolism
  • Matrix Metalloproteinase 14 / genetics
  • Matrix Metalloproteinase 14 / metabolism
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism
  • Mice
  • Osteocytes / drug effects*
  • Osteocytes / metabolism
  • Osteocytes / pathology
  • Osteonecrosis / chemically induced
  • Osteonecrosis / genetics
  • Osteonecrosis / metabolism
  • Osteonecrosis / pathology*
  • Osteoprotegerin / genetics
  • Osteoprotegerin / metabolism
  • Prednisolone / adverse effects*
  • RANK Ligand / genetics
  • RANK Ligand / metabolism
  • Tartrate-Resistant Acid Phosphatase / genetics
  • Tartrate-Resistant Acid Phosphatase / metabolism
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Delayed-Action Preparations
  • Glucocorticoids
  • Osteoprotegerin
  • RANK Ligand
  • TNFSF11 protein, human
  • TSC22D3 protein, human
  • Transcription Factors
  • Prednisolone
  • ACP5 protein, human
  • Tartrate-Resistant Acid Phosphatase
  • CTSK protein, human
  • Cathepsin K
  • MMP13 protein, human
  • Matrix Metalloproteinase 13
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP14 protein, human
  • Matrix Metalloproteinase 14